Eric Greig has joined Cooley LLP as a partner in the firm’s global life sciences and healthcare regulatory practice, reinforcing the firm’s presence in the evolving health sector landscape. Based in Washington, Greig’s expertise will be pivotal in advising clients across a broad spectrum of healthcare regulations and strategies encompassing medical devices, pharmaceuticals, digital health, biotechnology, diagnostics, and healthcare services.
Greig’s role will involve guiding clients through the intricacies of government reimbursement processes and providing advocacy with federal and state health agencies. His work will focus on matters related to coverage, coding, reimbursement, payment, and compliance—a comprehensive approach necessary for navigating the complexities of the healthcare industry. This move follows his tenure at the law firm Latham & Watkins, where he honed skills that will now benefit Cooley’s clientele.
The announcement was made on Tuesday, further indicating Cooley’s strategic push to expand its regulatory expertise within the life sciences domain. The firm aims to address the increasing demand for specialized legal guidance as the health sector continues to evolve rapidly.
For more details, the full story can be found on Bloomberg Law.